Acquired Organization:

  • Avid Radiopharmaceuticals Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.

Acquiring Organization:

  • Eli Lilly Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
  • Announced Date Nov 8, 2010
  • Acquisition Type Acquisition
  • Price $800M
  • Acquisition Status Complete
  • Disposition of Acquired Organization Subsidiary
  • Acquisition Terms Cash & Stock